Skip to content

Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep)

Comparison Of The Analgesia Obtained By Infiltration Of Lidocaïne 1% And Ropivacaïne 0,75% Versus Placebo For The Joinings Of Episiotomies Among Parturients Under Epidural Analgesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00727935
Acronym
LiRoPep
Enrollment
165
Registered
2008-08-04
Start date
2006-10-31
Completion date
Unknown
Last updated
2008-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childbirth, Parturients

Keywords

Women, parturients, with, realization, episiotomy

Brief summary

Lateral episiotomy is a current care practiced with childbirth room. One of the problems encountered with this surgical act is the residual pain on perineal scar level. Maximal during the first 24 hours, this pain can persist several days or several weeks hampering to variable degrees a normal recovery of autonomy and comfort of life. Some studies have shown the interest of ropivacaine, local anaesthetic with a long action's duration for proctologic surgeries and for the cure of inguinal hernia. A recent study shown the ropivacaine perineal infiltration used prior perineorrhaphy allows an absence of post-partum pain for 24 to 27% of cases and a first analgesics request delayed to ten hours. Methodology: 165 parturients having an epidural analgesia and an episiotomy were enrolled. The perineal infiltration was randomized according to 3 equal groups (placebo, ropivacaine 0,75%, lidocaine 1%) and realised prior perineorrhaphy. then The parturient were followed during the 24 first hours. This study was designed as double blind and the study conduct was standardized in order to get only variable such as the episiotomy infiltration.

Interventions

DRUGLidocaïne
DRUGPlacebo

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years

Inclusion criteria

Pre-inclusion criteria : * Assent of participation in the study signed * Major parturient (\> 18 years) in the course of work in room of childbirth * Mono-foetal pregnancy * Presentation at the top Inclusion Criteria: * Checking of the criteria of pre-inclusion * Oral confirmation of the assent of the patient * ASA 1 or 2 * Childbirth by low way * Patient having an epidural analgesia * Patient having an episiotomy * Counter-indication with the ropivacaïne Pre-

Exclusion criteria

: * Absence of signed assent of participation in the study * Counter indication with the lidocaïne * General counter-indications suitable for the epidural anaesthesia , independently of the local anaesthetic used * Counter-indications with the infiltration: patient under anticoagulants, coagulopathy * Allergy to the lidocaine or the ropivacaine * Allergy to the one of analgesics per bones used in the assumption of responsibility of routine * Severe insufficiency hepatic and/or renal and/or ulcerates gastro-duodénal (in the case of anti-inflammatory drug regulation not steroid during the postpartum) * Minor * Major protected within the meaning of the law Huriet * Patient during one time of exclusion following another biomedical study

Design outcomes

Primary

MeasureTime frame
Time between the infiltration of the local anaesthetic and the first analgesics catch per os, which is managed when the level of pain evaluated by EVA is higher than 30 mm1 year

Secondary

MeasureTime frame
To compare between the 3 groups the mean level of the pain during the first 24 hours following the joining of the episiotomy, measured by EVA24 hours
To compare between the 3 groups the analgesics overall consumption per os during the first 24 hours following the joining of the episiotomy24 hours
To compare between the 3 groups the total cost of the analgesics consumption (local anaesthetic employed and analgesics per bone) during the first 24 hours following the joining of the episiotomy24 hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026